Cargando…

Protective Effect of HLA-B*5701 and HLA-C -35 Genetic Variants in HIV-Positive Caucasians from Northern Poland

AIM OF THE STUDY: Association of two HLA class I variants with HIV-1 pretreatment viremia, CD4+ T cell count at the care-entry and CD4+ T cell nadir. METHODS: 414 HIV-positive Caucasians (30% women) aged 19-73 years were genotyped for HLA-C -35 (rs9264942) and HLA-B*5701 variants. HIV-1 viral load,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leszczyszyn-Pynka, Magdalena, Aksak-Wąs, Bogusz, Urbańska, Anna, Parczewski, Miłosz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4465896/ https://www.ncbi.nlm.nih.gov/pubmed/26068923 http://dx.doi.org/10.1371/journal.pone.0127867

Ejemplares similares

Influence of HLA-B*5701 on 20 year survival rate among patients living with HIV
por: Aksak-Wąs, Bogusz Jan, et al.
Publicado: (2021)

Correction: Influence of HLA-B*5701 on 20 year survival rate among patients living with HIV
por: Aksak-Wąs, Bogusz Jan, et al.
Publicado: (2022)

HIV-1 Subtype D Infections among Caucasians from Northwestern Poland—Phylogenetic and Clinical Analysis
por: Parczewski, Miłosz, et al.
Publicado: (2012)

Transmitted drug resistance to rilpivirine among antiretroviral-naïve patients living with HIV from northern Poland
por: Parczewski, Miłosz, et al.
Publicado: (2014)

Temporal increase in HIV-1 non-R5 tropism frequency among antiretroviral-naive patients from northern Poland
por: Parczewski, Milosz, et al.
Publicado: (2014)

The temporal increase in HIV-1 non-R5 tropism frequency among newly diagnosed patients from northern Poland is associated with clustered transmissions
por: Parczewski, Miłosz, et al.
Publicado: (2015)

Factors Influencing Immune Restoration in People Living with HIV/AIDS
por: Aksak-Wąs, Bogusz Jan, et al.
Publicado: (2022)

HLA-B*5701 testing to predict abacavir hypersensitivity
por: Ma, Joseph D., et al.
Publicado: (2010)

Risk of All-Cause Mortality in HIV Infected Patients Is Associated with Clinical, Immunologic Predictors and the CCR5 Δ32 Deletion
por: Parczewski, Milosz, et al.
Publicado: (2011)

Septic Shock Induced by Vibrio Vulnificus in Northern Poland, a Case Report
por: Aksak-Wąs, Bogusz Jan, et al.
Publicado: (2021)

Hepatitis C coinfection adversely affects the life expectancy of people living with HIV in northwestern Poland
por: Leszczyszyn-Pynka, Magdalena, et al.
Publicado: (2016)

HLA B(∗)5701 status, disease progression, and response to antiretroviral therapy
Publicado: (2013)

Phylodynamic Dispersal of SARS-CoV-2 Lineages Circulating across Polish–German Border Provinces
por: Serwin, Karol, et al.
Publicado: (2022)

Expanding HIV-1 subtype B transmission networks among men who have sex with men in Poland
por: Parczewski, Miłosz, et al.
Publicado: (2017)

CCR5 D32 modifies 15-year mortality risk associated with well-established clinical and immunological factors among HIV-infected patients
por: Parczewski, M, et al.
Publicado: (2010)

Prevalence of HLA-B*5701 and Its Relationship with Abacavir Hypersensitivity Reaction in Iranian HIV-Infected Patients
por: Baniasadi, Shadi, et al.
Publicado: (2016)

Prevalence of the HLA-B*5701 Allele and Abacavir Hypersensitivity in Saudi HIV Patients: A Multicenter Study
por: Alsaeed, Ali, et al.
Publicado: (2023)

Tocilizumab Use among Patients Who Developed Pulmonary Embolism in the Course of Cytokine Release Storm and COVID-19 Pneumonia—A Retrospective Study
por: Chober, Daniel, et al.
Publicado: (2022)

Frequency of HLA B*5701 allele carriers in abacavir treated-HIV infected patients and controls from northeastern Brazil
por: Crovella, Sergio, et al.
Publicado: (2011)

Cost impact of prospective HLA-B*5701-screening prior to abacavir/lamivudine fixed dose combination use in Germany
por: Wolf, E, et al.
Publicado: (2010)

Functional Differences Exist between TNFα Promoters Encoding the Common −237G SNP and the Rarer HLA-B*5701-Linked A Variant
por: Simpson, Peter D., et al.
Publicado: (2012)

Abacavir Hypersensitivity Reaction Reporting Rates During a Decade of HLA‐B*5701 Screening as a Risk‐Mitigation Measure
por: Stainsby, Chris M., et al.
Publicado: (2018)

HIV-1 integrase resistance among antiretroviral treatment naive and experienced patients from Northwestern Poland
por: Parczewski, Miłosz, et al.
Publicado: (2012)

Time trends in HIV-1 transmitted drug resistance mutation frequency in Poland
por: Parczewski, Milosz, et al.
Publicado: (2014)

Transmitted HIV drug resistance and subtype patterns among blood donors in Poland
por: Parczewski, Miłosz, et al.
Publicado: (2021)

ERAP1 and HLA-C*06 are strongly associated with the risk of psoriasis in the population of northern Poland
por: Stawczyk-Macieja, Marta, et al.
Publicado: (2018)

Baseline CD4(+) T Cell Counts Correlates with HIV-1 Synonymous Rate in HLA-B*5701 Subjects with Different Risk of Disease Progression
por: Norström, Melissa M., et al.
Publicado: (2014)

Comparing HLA Shared Epitopes in French Caucasian Patients with Scleroderma
por: Azzouz, Doua F., et al.
Publicado: (2012)

Fibrillary Glomerulonephritis Is Associated With HLA-DR7 and HLA-B35 Antigens
por: Andeen, Nicole K., et al.
Publicado: (2020)

Correction: Baseline CD4+ T Cell Counts Correlates with HIV-1 Synonymous Rate in HLA-B*5701 Subjects with Different Risk of Disease Progression
Publicado: (2014)

A Prospective Screening of HLA-B*57.01 Allelic Variant for Preventing the Hypersensivity Reaction to Abacavir: Experience from the Laboratory of Molecular Biology of the Infectious Diseases Division at the University Hospital of Salerno
por: Senatore, C, et al.
Publicado: (2014)

Significance of HLA in Graves’ disease and Graves’ orbitopathy in Asian and Caucasian populations – a systematic review
por: Stasiak, Magdalena, et al.
Publicado: (2023)

Effectiveness of Tocilizumab in Patients with Severe or Critical Lung Involvement in COVID-19: A Retrospective Study
por: Chober, Daniel, et al.
Publicado: (2022)

Cranial and extracranial giant cell arteritis do not have different HLA-DRB1 and HLA-B association in Caucasian individuals
por: Prieto-Peña, Diana, et al.
Publicado: (2021)

Letter Regarding “Fibrillary Glomerulonephritis Is Associated With HLA-DR7 and HLA-B35 Antigens”
por: El Ters, Mireille, et al.
Publicado: (2020)

Association of Protective HLA-A With HLA-B(∗)27 Positive Ankylosing Spondylitis
por: Nordin, Jessika, et al.
Publicado: (2021)

Improved survival in intensive care unit in severe COVID-19 associated with amantadine use - retrospective study
por: Chober, Daniel, et al.
Publicado: (2022)

Personalized HLA typing leads to the discovery of novel HLA alleles and tumor‐specific HLA variants
por: Anzar, Irantzu, et al.
Publicado: (2022)

The HLA Variant rs6903608 Is Associated with Disease Onset and Relapse of Immune-Mediated Thrombotic Thrombocytopenic Purpura in Caucasians
por: Mancini, Ilaria, et al.
Publicado: (2020)

Programmed Cell Death-1/Programmed Cell Death-1 Ligand as Prognostic Markers of Coronavirus Disease 2019 Severity
por: Niedźwiedzka-Rystwej, Paulina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6ogt7rsh2fl4jg8gnfoh2cep00